Cory Jubinville, PhD
Stock Analyst at LifeSci Capital
(4.73)
# 706
Out of 4,969 analysts
139
Total ratings
54.9%
Success rate
25.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cory Jubinville, PhD
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRME Prime Medicine | Reiterated: Buy | $6 | $3.18 | +88.68% | 11 | Aug 17, 2026 | |
| TNYA Tenaya Therapeutics | Reiterated: Buy | $4 | $0.6929 | +477.28% | 33 | Aug 6, 2026 | |
| MREO Mereo BioPharma Group | Reiterated: Hold | n/a | $0.28 | - | 14 | Jan 12, 2026 | |
| SION Sionna Therapeutics | Initiated Coverage: Buy | $60 | $8.26 | +626.39% | 1 | Dec 23, 2025 | |
| IKT Inhibikase Therapeutics | Initiated Coverage: Buy | $5 | $2.39 | +109.21% | 1 | Dec 1, 2025 | |
| TECX Tectonic Therapeutic | Reiterated: Buy | $88 | $29.71 | +196.20% | 5 | Nov 18, 2025 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Buy | $9 | $3.43 | +162.39% | 17 | Nov 7, 2025 | |
| LRMR Larimar Therapeutics | Reiterated: Buy | $22 | $3.78 | +482.01% | 21 | Nov 5, 2025 | |
| TARS Tarsus Pharmaceuticals | Reiterated: Buy | $85 → $84 | $79.95 | +5.07% | 14 | Nov 5, 2025 | |
| LQDA Liquidia | Reiterated: Buy | $54 → $67 | $65.31 | +2.60% | 22 | Nov 3, 2025 |
Prime Medicine
Aug 17, 2026
Reiterated: Buy
Price Target: $6
Current: $3.18
Upside: +88.68%
Tenaya Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $4
Current: $0.6929
Upside: +477.28%
Mereo BioPharma Group
Jan 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.28
Upside: -
Sionna Therapeutics
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $60
Current: $8.26
Upside: +626.39%
Inhibikase Therapeutics
Dec 1, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $2.39
Upside: +109.21%
Tectonic Therapeutic
Nov 18, 2025
Reiterated: Buy
Price Target: $88
Current: $29.71
Upside: +196.20%
Rocket Pharmaceuticals
Nov 7, 2025
Reiterated: Buy
Price Target: $9
Current: $3.43
Upside: +162.39%
Larimar Therapeutics
Nov 5, 2025
Reiterated: Buy
Price Target: $22
Current: $3.78
Upside: +482.01%
Tarsus Pharmaceuticals
Nov 5, 2025
Reiterated: Buy
Price Target: $85 → $84
Current: $79.95
Upside: +5.07%
Liquidia
Nov 3, 2025
Reiterated: Buy
Price Target: $54 → $67
Current: $65.31
Upside: +2.60%